Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The investigators propose to perform a randomized clinical trial comparing prasugrel vs.
ticagrelor in 60 patients with ST elevation acute myocardial infarction (STEMI) undergoing
primary percutaneous coronary intervention. The principal objective of the study would be
analyzing the difference in myocardial infarction size measured by cardiac magnetic resonance
at 6 months